Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1991-12-31
|
pubmed:abstractText |
Fluconazole is a recently licensed antifungal agent that has gained widespread use in the medical community. Despite a lack of controlled trials in invasive fungal infections, this agent is often prescribed because of ease of administration and concern over amphotericin B toxicity. Three cases of systemic fungal infections in which fluconazole use resulted in unambiguous microbiologic and clinical failure are reported.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
164
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1232-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1955725-Amphotericin B,
pubmed-meshheading:1955725-Candidiasis,
pubmed-meshheading:1955725-Coccidioidomycosis,
pubmed-meshheading:1955725-Fluconazole,
pubmed-meshheading:1955725-Humans,
pubmed-meshheading:1955725-Male,
pubmed-meshheading:1955725-Middle Aged,
pubmed-meshheading:1955725-Tomography, X-Ray Computed,
pubmed-meshheading:1955725-Treatment Outcome
|
pubmed:year |
1991
|
pubmed:articleTitle |
Fluconazole failure in the treatment of invasive mycoses.
|
pubmed:affiliation |
Division of Infectious Diseases, University of Utah, Salt Lake City.
|
pubmed:publicationType |
Journal Article,
Case Reports
|